Kymera Therapeutics Inc (KYMR)
R&D to Revenue
183.82%
Quarterly · Period ending:
KYMR R&D to Revenue
Latest reported183.82%period ending
Latest reported183.82%period ending
KYMR Quarterly R&D/Revenue (1190.53% → 183.82%)
Latest values, visible window
High-resolution chart · PNG
KYMR r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 183.8169% | |
| 285.6453% | |
| 2,932.2727% | |
| 2,680.6802% | |
| 683.0603% | |
| 363.1448% | |
| 971.2875% | |
| 1,614.8089% | |
| 230.807% | |
| 474.5698% | |
| 110.6192% | |
| 1,017.703% | |
| 277.1574% | |
| 446.0913% | |
| 267.2594% | |
| 459.3969% | |
| 358.633% | |
| 373.5606% | |
| 245.6956% | |
| 188.3655% | |
| 190.1831% | |
| 138.8194% | |
| 159.4994% | |
| 108.5667% | |
| 420.2859% | |
| 353.4422% | |
| 604.8009% | |
| 1,190.5263% |